Upcoming BioPharma Catalyst Trades to Consider
Upcoming BioPharma Catalyst Trades to Consider
Filed under: drug treatment news articles
I remarked in an article last March that Horizon Pharma (NASDAQ: HZNP) was a good mid-term catalyst trade heading into its PDUFA 7/26/12 of LODOTRA, a proprietary modified delayed-release formulation of prednisone for the treatment of rheumatoid …
Read more on Reuters
Doctors' groundbreaking research led to methadone's use in treating addiction
Filed under: drug treatment news articles
They started treating heroin addicts with methadone in 1964, finding that the drug blocked heroin's rush and instead provided a slow onset, reduced mood swings and offered the chance at a more productive life. Nyswander died in 1986; Dole died in …
Read more on Lodi News-Sentinel
Taking aim at age-old killer, India's hi-tech revolution sees new ways to …
Filed under: drug treatment news articles
New tests powered by computer chips are being rolled out that can quickly identify drug-resistant patients so they can be given the proper treatment with a longer course of different medicines. And Operation ASHA, an independent health group, is using …
Read more on Minneapolis Star Tribune
Pfizer announces FDA approval of new rheumatoid arthritis drug Xeljanz
Filed under: drug treatment news articles
The Food and Drug Administration (FDA) approved the medication Xeljanz, manufactured by Pfizer Inc., for treatment of moderate to severe rheumatoid arthritis on November 7, 2012. Xeljanz is seen as a probable high seller by Pfizer and is for people who …
Read more on Examiner.com